Overview / Experience
Experience
-
Jun 2025 –
presentPostdoctoral Researcher
University Hospital Bonn · Abdullah Lab · Bonn, Germany
Lead an independent research programme on unconventional T cell state transitions and tissue-resident immunity in antiviral and chronic disease.
- LCMV infection models to study T cell exhaustion and unconventional T cells.
- Single-cell and bulk sequencing analysis: scRNA-seq, scTCR-seq, scATAC-seq, bulk TCR-seq.
- Primary hiring lead for the lab's scientific recruitment. Mentor PhD and undergraduate researchers.
- Coordinate collaborations across Europe, Australia and Japan.
-
Jun 2023 –
Mar 2025Research Collaborator (Bioinformatics)
Axelia Oncology project, via the Bald Lab · Melbourne, Australia
Bioinformatics and immunological data analysis for a clinical-stage innate immunotherapy programme.
-
Mar 2020 –
Jun 2025Postdoctoral Researcher
University Hospital Bonn · Bald Lab · Bonn, Germany
Owned and led the NK cell cancer immunotherapy programme, studying NK cell plasticity and dysfunction in the tumour microenvironment.
- Analysed single-cell multi-omics (scRNA-seq, CITE-seq, scTCR-seq) and bulk RNA-seq across T and NK cell projects, and set up reproducible analysis pipelines for institute projects.
- Established CRISPR engineering of primary human and murine NK and CD8 T cells, and supervised CAR-NK and CAR-T projects.
- Syngeneic and humanised tumour models with high-dimensional spectral cytometry.
- Helped build the institute's flow cytometry, high-multiplex spatial imaging and patient-derived organoid capacity, and established its patient-derived biobank.
- Won project funding as an independent applicant.
- Co-supervised PhD, Masters and BSc students, and taught the tumour immunology Masters practical course.
- PaperType I IFN drives a TCR-stimulation-inert T cell state European Journal of Immunology 2025, first author
- PaperNKG7 as a stable cytotoxicity marker European Journal of Immunology 2025, senior author
- PaperGLORIA phase I/II glioblastoma trial Nature Communications 2024
- PaperRegulatory T cells limit bispecific antibody therapy Haematologica 2024
- CodeCorvino_etal_2024_EJI
- GrantBMBF GO-Bio Initial · €100k · principal investigator
- GrantImmunoSensation2 Postdoc Innovation Fund · €10k · sole applicant
-
Sep 2019 –
Feb 2020Postdoctoral Researcher
QIMR Berghofer · Bald Lab · Brisbane, Australia
Profiled tumour-infiltrating lymphocytes from head and neck squamous cell carcinoma patients with scRNA-seq, scTCR-seq and CITE-seq.
- Characterised inhibitory receptor landscapes and functional heterogeneity of NK and CD8 T cells.
- Tested immunotherapy hypotheses in in vivo tumour models. The results informed biomarker prioritisation.
- PaperNKG7 regulates cytotoxic granule exocytosis Nature Immunology 2020
- PaperCD155 drives degradation of CD226 in CD8 T cells Immunity 2020
-
Apr 2015 –
Sep 2019PhD, Immunology
University of Queensland (QIMR Berghofer) · Supervisor Prof. Rajiv Khanna · Brisbane, Australia
Thesis: strategies for improving adoptive T cell immunotherapy.
- Developed and characterised antigen-specific T cell therapy products against viral and tumour targets.
- Established humanised mouse models and analysed bulk TCR-seq and RNA-seq data.
- PaperT cell repertoire remodelling after T cell therapy Journal of Clinical Investigation 2019
- PatentProvisional AU 2017904567 · biomarkers of immunocompetence
-
2011 – 2014
Bachelor of Biomedical Science, Honours Class I
Griffith University · Australia
cGPA 6.83 / 7.0.
Independent projects
- Built with Claude hackathon, 2026
- Life Sciences hackathon (Anthropic, Gladstone Institutes), selected by application. Built a Python mtDNA clone-calling package, integrated public scTCR-seq and mtDNA lineage-tracing data on the origins of human NK cells, and reproduced a published NK trajectory analysis on HPC. Thymic_NK_development
- r-utility-functions
- R package of tested single-cell, bulk RNA-seq and cancer-genomics helpers, with continuous integration, documentation site and Zenodo DOI. r-utility-functions
- NKG7 structure and binders
- Structural and evolutionary characterisation of NKG7 and de novo mini-binder design against its extracellular loops. nkg7-structural-analysis, nkg7-binder-design
- lab-protocols
- Standardised wet-lab and computational protocols. lab-protocols
Leadership
- Programme ownership
- Set scientific direction, project design, milestones and resourcing for an independent programme, running wet-lab and computational workstreams in parallel.
- Hiring
- Full-cycle recruitment of PhD students and technicians: role definition, shortlisting, interview panels, onboarding.
- Supervision and teaching
- Co-supervised 3 PhD, 3 Masters and 8 BSc and rotation students. Taught the tumour immunology Masters practical course and run bioinformatics training for wet-lab scientists.
- Lab and infrastructure
- Helped build the institute's flow cytometry (panels, training, SOPs), spatial imaging and organoid programme, and its biobank. Lab operations, procurement and ethics compliance.
- Collaboration
- Clinical and computational collaborations across Europe, the United States, Australia and Japan, and day-to-day communication between wet-lab and dry-lab teams.
- Communication
- Manuscript writing and revision, publication figures (ggplot2, Illustrator), grant writing and reporting, seminar presentations.
Funding and awards
- GO-Bio Initial, BMBF · principal investigator · €100,000 2023
- ImmunoSensation2 Postdoc Innovation Fund · sole applicant · €10,000 2020
- Provisional patent, inventor: Biomarkers of immunocompetence and uses therefor AU 2017904567
Service and talks
- Peer reviewer for Immunity, Nature Communications, Cancer Immunology Research, Genome Biology and Scientific Reports.
- Small population, big potential: identifying a precursor to tumour-infiltrating group 1 ILCs Immunology Seminar Series, University Hospital Bonn, 2023
- NK cell plasticity in cancer Malmberg laboratory, University Hospital Oslo, 2022
- Use of oligo-based barcoding to track NK cell plasticity in cancer ImmunoSensation2 online conference, 2020